• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  06/29/2005
Trade Name:  Topamax Tablets and Sprinkle Capsules
Generic Name or Proper Name (*):  topiramate
Indications Studied:  Initial monotherapy for partial onset or primary generalized tonic-clonic seizures in children 10 years of age and older
Label Changes Summary:  * Effectiveness established in studies of patients down to 6 years of age * Use in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials * Provides information regarding treatment-emergent decrease in serum bicarbonate and adverse events * Some patients in the study discontinued therapy due to adverse events; however, adverse events associated with discontinuing therapy included difficulty with concentration/attention * Studies waived in children 0-2 years of age; deferred in children 2-10 years of age * New indication
Product Labeling:  Labeling  Opens a new window
Sponsor:  Johnson & Johnson
Therapeutic Category:  Anticonvulsant